Aspire Biopharma Holdings, Inc. (ASBP)
Aspire Biopharma Holdings, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Aspire Biopharma Holdings, Inc. (ASBP) is a Biotechnology company based in US with a market capitalization of $627.6K. Free cash flow was negative at -$4.9M. This page tracks ASBP's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 2 employees · IPO Feb 20, 2025
Valuation
Valuation & price
$5.61as of May 17, 2026· -99.2% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
—
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$627.6K
Market cap
—
Revenue growth (YoY)
-1.9%
Gross margin
-$4.9M
Free cash flow (USD)
$380.9K
Net debt
116.7%
Share dilution
0/4
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2021 → 2025
Free cash flow by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last reported: May 15, 2026 (EPS $-20.57)
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- 8-K eventJul 20, 2026Filing
Warrant Terms Clarification
- 8-K eventJun 22, 2026Filing
Stockholder Meeting Results
- 8-K eventJun 12, 2026Filing
Acquisition Announced
- 8-K eventJun 12, 2026Filing
Shareholder Meeting Adjourned
- Quarterly reportMay 15, 2026Filing
10-Q Filed
- 8-K eventMay 14, 2026Filing
Reverse Stock Split
- 8-K eventApr 20, 2026Filing
Private Placement Completed
- 8-K eventApr 17, 2026Filing
Securities Offering Completion
- 8-K eventApr 16, 2026Filing
Acquisition Announced
- 8-K eventApr 16, 2026Filing
Stockholder Meeting Results
Questions
Frequently asked questions
What is Aspire Biopharma Holdings, Inc.'s market cap?
Aspire Biopharma Holdings, Inc. (ASBP) has a market capitalization of $627.6K.
What is ASBP's P/E ratio?
A meaningful P/E ratio is not available for ASBP — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
When did Aspire Biopharma Holdings, Inc. last report earnings?
ASBP last reported earnings on May 15, 2026; the next date is not yet scheduled.
Are insiders buying ASBP stock?
SEC Form 4 filings show no open-market insider buys at Aspire Biopharma Holdings, Inc. in the last 90 days (0 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.